Defects in genes encoding for proteins involved in regulatory mechanisms of both blood pressure and glucose metabolism, have become the target of studies to help explain the pathogenesis of complex diseases, such as diabetes and hypertension.
A polymorphic variant of the glucagon-receptor (GCGR) gene has been associated with Type 2 diabetes in various white European populations 5, 6 and with hypertension in both European whites 7, 8 and Australians. 9 The Gly40Ser variant results in a missense mutation at codon 40 in exon 2 of the GCGR gene leading to the substitution of a serine for a glycine amino-acid residue in the encoded protein. The mutation is located within an extracellular domain of the receptor. 5 In vitro studies suggest that this variant results in a reduced affinity of the receptor for the agonist and in a concomitant reduced synthesis of cyclic-adenosine monophosphate by the target cell. 10 This polymorphism is also associated with central adiposity independent from total body mass in white men, 11 suggesting that it might play a role in the metabolic syndrome in white populations. The frequency of this variant ranges from 2 to 8% in French, 7 British, 6 Italian 8 and Australian 9 white populations, whereas it was very rare in studies in Finnish, 12 German 13 and Brazilian 14 and absent in German, 15 Japanese 16, 17 and Chinese 18 populations. Given that hypertension, diabetes and the metabolic syndrome are more prevalent in South Asians and in people of black African origin, it is of interest to establish the frequency of this polymorphism in such populations and to assess its potential role.
The study methodology is reported in detail elsewhere. 1, 19 In brief, participants were recruited from the lists of general practices in South London. From each participating practice, a list was obtained of all men and women aged 40-59 years, registered with the practice and resident within the study area. The final sample size was 1577. The protocol was approved by the Local Ethics Committee. All participants gave their informed consent to participate. They attended a dedicated screening unit at St. George's Hospital. The examination included anthropometry, blood pressure, a detailed questionnaire and a fasting blood test. The DNA isolation protocol has been described in detail previously. 20 Restriction fragment length polymorphism analysis (RFLP) was carried out as described elsewhere. 8, 11 Valid genotyping was obtained in 1407 (89.2%) of the total subjects (466 of the white population, 477 of African origin and 452 South Asians). The characteristics of those not genotyped did not differ from the rest of the population (data not shown). A 10% random sample of the study population and all the heterozygotes were double genotyped in a blinded fashion. Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS-PC 10). The calculation of allele frequency to test for HardyWeinberg equilibrium for each of the two ethnic groups was carried out using standard methods; w 2 tests were used to compare expected against observed frequencies in South Asians and white populations. Means were compared by analysis of covariance allowing for confounders. Results are expressed as means or percentages with corresponding approximate 95% confidence intervals (CI).
The Gly40Ser variant was present in 12 subjects or 0.85% (95% CI: 0.68-1.13%) and none was homozygous. The allele distribution followed the HardyWeinberg equilibrium. Among the white populations, the frequency of the variant was 1.89% (0.67-3.13%) or 9/475, a frequency compatible with those found in other white populations. However, in South Asians the frequency was much lower at 0.66% (0.43-0.97%) or 3/455 and absent in people of African origin. In white populations, the presence of the variance did not appear to be associated with higher blood pressure levels or with increased levels of metabolic markers of insulin resistance or diabetes ( Table 1 ).
The present study confirms that in a white British population, the frequency of the Gly40Ser variant of the GRCG gene is not very common and only accounts for not more than 3%. These figures are compatible with those reported in other studies on white populations in Europe [5] [6] [7] [8] 10, 12, 13 and elsewhere.
14 Conversely, our study reveals that the Gly40Ser variant of the GCGR was absent in a sample of adult men and women of black African origin and very rare in a comparable sample of South Asian men and women.
The link of this genetic variant to the development of hypertension is postulated through the involvement of both glucagon 21 and c-AMP metabolism. 22 Glucagon may have a natriuretic effect through stimulation of hepatic c-AMP, increased levels of circulating c-AMP and a reduction of solute and water reabsorption in the pars recta of the renal proximal tubule. 22 The polymorphic variant of the receptor, which is less sensitive to agonist stimulation and results in a lower production of c-AMP by the liver cells, would induce sodium and water retention and hypertension. This hypothesis could explain the recently reported reduced fractional excretion of exogenous lithium and uric acid in white men carrying the Gly40Ser variant. 8 On the other hand, the link of this genetic variant to the development of diabetes is postulated through either a less responsive receptor to endogenous glucagon to protect against hyperglycaemia, 5, 10 or through stimulation of insulin production in response to glucagon binding to pancreatic islet betacells. 23 Considering the high prevalence of hypertension and diabetes among South Asians and people of black African origin, 1 it is unlikely that this variant plays an important role in the development of these two common diseases in these two ethnic groups. Indeed, given the very low population frequency, the potential population attributable risk would be negligible. 
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